Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis. [electronic resource]
Producer: 20200720Description: 576-587 p. digitalISSN:- 2326-5205
- Adult
- Aged
- Animals
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antirheumatic Agents -- pharmacology
- Arthritis, Experimental -- drug therapy
- Arthritis, Rheumatoid -- drug therapy
- Cell Proliferation
- Female
- Forkhead Transcription Factors -- metabolism
- Humans
- Male
- Mice
- Middle Aged
- Receptors, Tumor Necrosis Factor, Type II -- genetics
- Spondylarthritis -- drug therapy
- T-Lymphocytes, Regulatory -- metabolism
- Tumor Necrosis Factor Inhibitors -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.